NeOnc Technologies Holdings, Inc. Common Stock

Market Cap

$118M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$3.54-$5.34 (-60.14%)

Jul 15, 2026

52W High $12.0952W Low $3.54

Company Details

NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies. Its lead product candidates include NEO100, a purified form of preillyl acid that is in Phase IIa...

Leadership

Amir Farrokh Heshmatpour

President, CEO, Executive Chairman & Secretary

Thomas C. Chen M.D., Ph.D.Founder

Founder, Chief Medical Officer, Chief Scientific Officer & Vice Chairman

Keithly A. Garnett

Chief Financial Officer

Josh Neman-Ebrahim Ph.D.

Chief Clinical Officer

David Choi Jr.

Chief Accounting Officer

IPO Date

Mar 26, 2025

Website

www.neonc.com

Key Metrics TTM

Revenue

-100.0% YoY

Net Income

-$39M

EPS (Diluted)

Free Cash Flow

-$22M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee